Current Report Filing (8-k)
01 October 2022 - 6:16AM
Edgar (US Regulatory)
0001839530
false
--12-31
0001839530
2022-09-27
2022-09-27
0001839530
CFFE:UnitsEachConsistingOfOneShareOfClassCommonStockAndOnefourthOfOneRedeemableWarrantMember
2022-09-27
2022-09-27
0001839530
CFFE:ClassCommonStockParValue0.0001PerShareMember
2022-09-27
2022-09-27
0001839530
CFFE:RedeemableWarrantsExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50PerShareMember
2022-09-27
2022-09-27
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
September 30, 2022 (September 27, 2022)
CF ACQUISITION CORP. VIII
(Exact name of registrant as specified in its charter)
Delaware |
|
001-40206 |
|
85-2002883 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
110 East 59th Street
New York, NY 10022
(Address of principal executive offices, including
zip code)
Registrant’s telephone number,
including area code: (212) 938-5000
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant |
|
CFFEU |
|
The Nasdaq Stock Market LLC |
|
|
|
|
|
Class A common stock, par value $0.0001 per share |
|
CFFE |
|
The Nasdaq Stock Market LLC |
|
|
|
|
|
Redeemable warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share |
|
CFFEW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01. Entry
into a Material Definitive Agreement.
On
September 30, 2022, CF Acquisition Corp. VIII (the “Company”) issued a promissory note (the “Note”)
in the principal amount of $976,832.34 to CFAC Holdings VIII, LLC (the “Sponsor”), pursuant to which the Sponsor
loaned to the Company $976,832.34, or $0.33 per share of the Company’s Class A common stock sold in the Company’s initial
public offering (“Public Share”) that was not redeemed in connection with the extension of the Company’s time
to consummate a business combination from September 30, 2022 to March 16, 2023.
On
September 30, 2022, the Company deposited such funds into the Company’s trust account, which amount will be included in the pro
rata amount distributed to (i) all of the holders of Public Shares upon the Company’s liquidation or (ii) holders of Public
Shares who elect to have their shares redeemed in connection with the consummation of the Company’s initial business combination.
The
Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of the Company’s initial business
combination or (b) the date of the liquidation of the Company.
The
issuance of the Note was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933,
as amended.
The
foregoing description is qualified in its entirety by reference to the Note, a copy of which is attached as Exhibit 10.1 hereto and is
incorporated herein by reference.
Item 2.03. Creation
of a Direct Financial Obligation or an Obligation Under an Off-balance Sheet Arrangement of a Registrant.
The
disclosure contained in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.
Item 5.03. Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On
September 29, 2022, the Company filed a second amendment to the Company’s Amended and Restated Certificate of Incorporation with
the Secretary of State of the State of Delaware (the “Extension Amendment”). The Extension Amendment extends the date
by which the Company must consummate its initial business combination from September 30, 2022 to March 16, 2023.
The
foregoing description is qualified in its entirety by reference to the Extension Amendment, a copy of which is attached as Exhibit
3.1 hereto and is incorporated by reference herein.
Item 5.07. Submission
of Matters to a Vote of Security Holders.
On
September 27, 2022, the Company held a special meeting of stockholders in lieu of the 2021 annual meeting (the “Meeting”).
At the Meeting, the Company’s stockholders approved the Extension Amendment extending the date by which the Company must consummate
its initial business combination from September 30, 2022 to March 16, 2023 (the “Extension Amendment Proposal”).
The
final voting results for the Extension Amendment Proposal were as follows:
For |
|
Against |
|
Abstain |
|
Broker Non-Votes |
24,419,214 |
|
133,847 |
|
0 |
|
0 |
Stockholders
holding 19,159,975 Public Shares exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s
trust account. As a result, approximately $196.1 million (approximately $10.24 per share) will be removed from the Company’s trust
account to pay such holders. Following redemptions, the Company will have 2,960,098 Public Shares outstanding.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
The following exhibits are being filed herewith:
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
CF Acquisition Corp. VIII |
|
|
|
Dated: September 30, 2022 |
By: |
/s/ Howard W. Lutnick |
|
|
Name: |
Howard W. Lutnick |
|
|
Title: |
Chief Executive Officer |
3
CF Acquisition Corporati... (NASDAQ:CFFE)
Historical Stock Chart
From Dec 2024 to Jan 2025
CF Acquisition Corporati... (NASDAQ:CFFE)
Historical Stock Chart
From Jan 2024 to Jan 2025